<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39040190</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.02.21.24303099</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.02.21.24303099</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Post-acute sequelae of SARS-CoV-2, referred to as "long COVID", are a globally pervasive threat. While their many clinical determinants are commonly considered, their plausible social correlates are often overlooked.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To compare social and clinical predictors of differences in quality of life (QoL) with long COVID. Additionally, to measure how much adjusted associations between social factors and long COVID-associated quality of life are unexplained by important clinical intermediates.</AbstractText><AbstractText Label="DESIGN SETTING AND PARTICIPANTS" NlmCategory="UNASSIGNED">Data from the ISARIC long COVID multi-country prospective cohort study. Subjects from Norway, the United Kingdom (UK), and Russia, aged 16 and above, with confirmed acute SARS-CoV-2 infection reporting &gt;= 1 long COVID-associated symptoms 1+ month following infection.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">The social exposures considered were educational attainment (Norway), employment status (UK and Russia), and female vs male sex (all countries).</AbstractText><AbstractText Label="MAIN OUTCOME AND MEASURES" NlmCategory="UNASSIGNED">Quality of life-adjusted days, or QALDs, with long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">This cohort study included a total of 3891 participants. In all three countries, educational attainment, employment status, and female sex were important predictors of long COVID QALDs. Furthermore, a majority of the estimated relationships between each of these social correlates and long COVID QALDs could not be attributed to key long COVID-predicting comorbidities. In Norway, 90% (95% CI: 77%, 100%) of the adjusted association between the top two quintiles of educational attainment and long COVID QALDs was not explained by clinical intermediates. The same was true for 86% (73%, 100%) and 93% (80%,100%) of the adjusted associations between full-time employment and long COVID QALDs in the United Kingdom (UK) and Russia. Additionally, 77% (46%,100%) and 73% (52%, 94%) of the adjusted associations between female sex and long COVID QALDs in Norway and the UK were unexplained by the clinical mediators.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">This study highlights the role of socio-economic status indicators and female sex, in line with or beyond commonly cited clinical conditions, as predictors of long COVID-associated QoL, and further reveal that other (non-clinical) mechanisms likely drive their observed relationships. Our findings point to the importance of COVID interventions which go further than an exclusive focus on comorbidity management in order to help redress inequalities in experiences with this chronic disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menkir</LastName><ForeName>Tigist F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Harvard University, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ISARIC, Pandemic Sciences Institute, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Citarella</LastName><ForeName>Barbara Wanjiru</ForeName><Initials>BW</Initials><AffiliationInfo><Affiliation>ISARIC, Pandemic Sciences Institute, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2764-1177</Identifier><AffiliationInfo><Affiliation>ISARIC, Pandemic Sciences Institute, University of Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doshi</LastName><ForeName>Yash</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Terna Speciality Hospital &amp; Research Centre, Mumbai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Luis Felipe</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>ISARIC, Pandemic Sciences Institute, University of Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de La Sabana, Chia, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinica Universidad de La Sabana, Chia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvache</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Departamento de Anestesiolog&#xed;a, Universidad del Cauca, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Erasmus University Medical Center, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kildal</LastName><ForeName>Anders Benjamin</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, University Hospital of North Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health Sciences, UIT The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nygaard</LastName><ForeName>Anders B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holter</LastName><ForeName>Jan Cato</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panda</LastName><ForeName>Prasan Kumar</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>All India Institute of Medical Sciences (AIIMS), Rishikesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jassat</LastName><ForeName>Waasila</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Institute for Communicable Diseases, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Right to Care, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merson</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4168-1960</Identifier><AffiliationInfo><Affiliation>ISARIC, Pandemic Sciences Institute, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnelly</LastName><ForeName>Christl A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-0195-2463</Identifier><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics and Department of Infectious Disease Epidemiology, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santillana</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Harvard University, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Machine Intelligence Group for the Betterment of Health and the Environment, Network Science Institute, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buckee</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8386-5899</Identifier><AffiliationInfo><Affiliation>Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard TH Chan School of Public Health, Harvard University, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verguet</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hejazi</LastName><ForeName>Nima S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Harvard TH Chan School of Public Health, Harvard University, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ISARIC Clinical Characterisation Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 GM130668</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007535</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CoiStatement>MS has received institutional research funds from the Johnson and Johnson foundation and from Janssen global public health. MS also received institutional research funding from Pfizer.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39040190</ArticleId><ArticleId IdType="pmc">PMC11261939</ArticleId><ArticleId IdType="doi">10.1101/2024.02.21.24303099</ArticleId><ArticleId IdType="pii">2024.02.21.24303099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). (2022).</Citation></Reference><Reference><Citation>O&#x2019;Mahoney L. L. et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine 55, 101762 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P. et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J Med Virol 94, 253&#x2013;262 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H. et al. Attributes and predictors of long COVID. Nat Med 27, 626&#x2013;631 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E. J. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun 13, 3528 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V. et al. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med 183, 566 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A. et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 28, 1706&#x2013;1714 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services. Social Determinants of Health.</Citation></Reference><Reference><Citation>Jones C. P., Jones C. Y., Perry G. S., Barclay G. &amp; Jones C. A. Addressing the Social determinants of children&#x2019;s Health: A cliff Analogy. JHCPU 20, 1&#x2013;12 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20168027</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z., Altiery De Jesus V., Assoumou S. A. &amp; Greenhalgh T. Long COVID and Health Inequities: The Role of Primary Care. Milbank Q 99, 519&#x2013;541 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bibbins-Domingo K. Integrating Social Care Into the Delivery of Health Care. JAMA 322 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31553407</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabnam S. et al. Socioeconomic inequalities of Long COVID: a retrospective population-based cohort study in the United Kingdom. J R Soc Med 116, 263&#x2013;273 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10469969</ArticleId><ArticleId IdType="pubmed">37164035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick J. L. et al. Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics. Clin Infect Dis 73, 2055&#x2013;2064 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller S. A. et al. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review. Lancet Glob Health 11, e1713&#x2013;e1724 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37858583</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson-Lane S. G. et al. Race, Ethnicity, and 60-Day Outcomes After Hospitalization With COVID-19. J Am Med Dir Assoc 22, 2245&#x2013;2250 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490827</ArticleId><ArticleId IdType="pubmed">34716006</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S. et al. The impact of ethnicity on the long-term sequelae of COVID-19: Follow-up from the first and second waves in North London. Thorax. 76, A141 (2021).</Citation></Reference><Reference><Citation>Vahidy F. S. et al. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open 10, e039849 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418666</ArticleId><ArticleId IdType="pubmed">32784264</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C., Ayoubkhani D. et al. Short Report on Long COVID. (2021).</Citation></Reference><Reference><Citation>Santamaria-Garcia H. et al. Factors associated with healthy aging in Latin American populations. Nat Med 29, 2248&#x2013;2258 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504086</ArticleId><ArticleId IdType="pubmed">37563242</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J. et al. Educational inequalities in mortality and their mediators among generations across four decades: nationwide, population based, prospective cohort study based on the ChinaHEART project. BMJ 382, e073749 (2023) doi:10.1136/bmj-2022-073749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-073749</ArticleId><ArticleId IdType="pmc">PMC10354660</ArticleId><ArticleId IdType="pubmed">37468160</ArticleId></ArticleIdList></Reference><Reference><Citation>ISARIC Clinical Characterization Group et al. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19. Sci Data 9, 454 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9339000</ArticleId><ArticleId IdType="pubmed">35908040</ArticleId></ArticleIdList></Reference><Reference><Citation>International Severe Acute Respiratory and emerging infection Consortium. COVID-19 Long term protocol. https://isaric.org/research/covid-19-clinical-research-resources/covid-19-long-term-follow-up-study/</Citation></Reference><Reference><Citation>Menkir T. &amp; ISARIC Working Group. The relative influence of clinical and sociodemographic variables on the long-term COVID-19-associated QALYs lost: Analysis Plan. (2022).</Citation></Reference><Reference><Citation>Euroqol. EQ-5D-5L | About. (2021). https://euroqol.org/information-and-support/euroqol-instruments/eq-5d-5l/</Citation></Reference><Reference><Citation>Sandmann F. G. et al. Long-Term Health-Related Quality of Life in Non-HospitalizedCoronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls. Clin Infect Dis 75, e962&#x2013;e973 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903473</ArticleId><ArticleId IdType="pubmed">35245941</ArticleId></ArticleIdList></Reference><Reference><Citation>Breiman L. Random Forests. Machine Learning 45 (2001).</Citation></Reference><Reference><Citation>Hejazi N. S., Rudolph K. E., Van Der Laan M. J. &amp; D&#xed;az I. Nonparametric causal mediation analysis for stochastic interventional (in)direct effects. Biostatistics 24, 686&#x2013;707 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10345989</ArticleId><ArticleId IdType="pubmed">35102366</ArticleId></ArticleIdList></Reference><Reference><Citation>Hejazi N., Rudolph K. &amp; D&#xed;az I. medoutcon: Nonparametric efficient causal mediationanalysis with machine learning in R. JOSS 7, 3979 (2022).</Citation></Reference><Reference><Citation>Robins J.M. &amp; Greenland S. Identifiability and Exchangeability for Direct and Indirect Effects. Epidemiology 3 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1576220</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkeser D., D&#xed;az I. &amp; Carone M. Statistical Learning in Mediation Analysis - Chapter 3: Natural direct and indirect effects. (2021).</Citation></Reference><Reference><Citation>Qeadan F. et al. Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites. Sci Rep 11, 8738 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062526</ArticleId><ArticleId IdType="pubmed">33888833</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele T. &amp; Vansteelandt S. Mediation Analysis with Multiple Mediators. Epidemiologic Methods 2 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287269</ArticleId><ArticleId IdType="pubmed">25580377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B. et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J. et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg Microbes &amp; infect 12, 2220578 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith L. H. Selection Mechanisms and Their Consequences: Understanding and Addressing Selection Bias. Curr Epidemiol Rep 7, 179&#x2013;189 (2020).</Citation></Reference><Reference><Citation>US National Center for Health Statistics. Long COVID: Household Pulse Survey. (2022).https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>